Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Healthcare Utilization in Patients With Acute Migraine: Pre- and Post-Treatment With INP104 in a Phase 3 Study

Presented at the 2021 Virtual AAN Annual Meeting. April 17-21, 2021 Authors: Carrie Dougherty, Sheena Aurora, Stephanie Bariahtaris, Stephen Shrewsbury, Marissa Baker-Wagner, Naomi Sacks, Sharon Kautz, Phil Cyr, Benjamin Friedman Objective: To assess certain healthcare resource utilization (HCRU) impacts of…

Cardiovascular Safety Results of INP104 (POD-DHE) from the STOP 301 Phase 3 Study

Presented at the 2021 Virtual AAN Annual Meeting. April 17-21, 2021 Authors: Karen Craig, John Hoekman, Maria Jeleva, Jasna Hocevar-Trnka, Sheena Aurora, Stephen Shrewsbury Objective: To report the cardiovascular results of INP104 from the STOP 301 study. Background: DHE product…

A Long-term, Open-label Safety and Tolerability Study of Precision Olfactory Delivery of DHE in Acute Migraine Treatment (STOP 301): Exploratory Efficacy Results

Presented at the 2021 Virtual AAN Annual Meeting. April 17-21, 2021 Authors: Sheena Aurora, Timothy Smith, Maria Jeleva, Jasna Hocevar-Trnka, John Hoekman, Stephen Shrewsbury Objective: To report the results of the exploratory, self-reported efficacy data for INP104 from the phase…

14 15 16